Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,364,241
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
11,121,954
-
Shares change
-
+280,756
-
Total reported value, excl. options
-
$62,947,464
-
Value change
-
+$1,581,064
-
Number of buys
-
13
-
Number of sells
-
11
-
Price
-
$5.65
Institutional Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q4 2019
As of 31 Dec 2019 scPharmaceuticals Inc. - Common Stock (SCPH) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,121,954 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, RA CAPITAL MANAGEMENT, L.P., Eversept Partners, LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Worth Venture Partners, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Squarepoint Ops LLC, and Alambic Investment Management, L.P..
This table shows 35 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.